Zelira Therapeutics Ltd (ZLD)

Sydney
Currency in AUD
0.400
0.000(0.00%)
Closed·
ZLD Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
ZLD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4000.400
52 wk Range
0.2801.090
Key Statistics
Edit
Bid/Ask
0.40 / 0.415
Prev. Close
0.4
Open
0.4
Day's Range
0.4-0.4
52 wk Range
0.28-1.09
Volume
3.79K
Average Volume (3m)
4.35K
1-Year Change
-11.11%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZLD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Zelira Therapeutics Ltd News & Analysis

Show more

Zelira Therapeutics Ltd Company Profile

Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a variety of medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid drug for the treatment of chronic insomnia. The company also provides over the counter products, including SprinJene, an oral care product; and acne treatment products under the RAF FIVE name, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. In addition, it offers products for autism and chronic noncancer pain. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is headquartered in Perth, Australia.

Compare ZLD to Peers and Sector

Metrics to compare
ZLD
Peers
Sector
Relationship
P/E Ratio
−1.0x−6.0x−0.5x
PEG Ratio
−0.01−0.050.00
Price/Book
−0.6x3.0x2.6x
Price / LTM Sales
116.4x7.9x3.1x
Upside (Analyst Target)
-291.5%50.4%
Fair Value Upside
Unlock18.9%8.7%Unlock

Earnings

Latest Release
Feb 26, 2025
EPS / Forecast
-0.21 / --
Revenue / Forecast
655.00 / --
EPS Revisions
Last 90 days

ZLD Income Statement

FAQ

What Is the Zelira Therapeutics (ZLD) Stock Price Today?

The Zelira Therapeutics stock price today is 0.40

What Stock Exchange Does Zelira Therapeutics Trade On?

Zelira Therapeutics is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Zelira Therapeutics?

The stock symbol for Zelira Therapeutics is "ZLD."

What Is the Zelira Therapeutics Market Cap?

As of today, Zelira Therapeutics market cap is 4.76M.

What Is Zelira Therapeutics's Earnings Per Share (TTM)?

The Zelira Therapeutics EPS (TTM) is -0.43.

From a Technical Analysis Perspective, Is ZLD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Zelira Therapeutics Stock Split?

Zelira Therapeutics has split 7 times.

How Many Employees Does Zelira Therapeutics Have?

Zelira Therapeutics has 0 employees.

What is the current trading status of Zelira Therapeutics (ZLD)?

As of 13 June 2025, Zelira Therapeutics (ZLD) is trading at a price of 0.40, with a previous close of 0.40. The stock has fluctuated within a day range of 0.40 to 0.40, while its 52-week range spans from 0.28 to 1.09.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.